There have been 40 recent insider transactions recorded for NRx Pharmaceuticals, Inc. (NRXPW), including 26 buys and 7 sells. Total insider buying was valued at $2.09M and total insider selling at $750.7K.
Notable insiders with recent activity include Casper Joseph Michael, B Group, Inc., Javitt Jonathan C. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NRXPW
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-01-27 |
Casper Joseph Michael |
Chief Operating Officer |
Unknown |
100,000 |
$2.39 |
$239K |
- |
| 2026-01-27 |
Casper Joseph Michael |
Chief Operating Officer |
RSU Award |
100,000 |
$2.39 |
$239K |
100,000 |
| 2025-08-18 |
B Group, Inc. |
10 Percent Owner |
Unknown |
- |
- |
- |
3,000,000 |
| 2025-04-09 |
Javitt Jonathan C |
10 Percent Owner, Officer: Chairman and Chief Scientist |
RSU Award |
125,000 |
$1.73 |
$216.21K |
125,000 |
| 2025-04-09 |
Hurvitz Chaim |
Director |
RSU Award |
25,000 |
$1.73 |
$43.24K |
25,000 |
| 2025-04-09 |
Flynn Patrick John |
Director |
RSU Award |
50,000 |
$1.73 |
$86.49K |
50,000 |
| 2025-04-09 |
Mcbride Dennis |
Director |
RSU Award |
25,000 |
$1.73 |
$43.24K |
25,000 |
| 2025-02-07 |
Abrams Michael S |
Chief Financial Officer |
RSU Award |
50,000 |
$2.94 |
$147K |
50,000 |
| 2024-12-17 |
Javitt Jonathan C |
10 Percent Owner, Officer: Chairman and Chief Scientist |
Informative Buy |
40,000 |
$1.17 |
$46.8K |
84,634 |
| 2024-11-18 |
Abrams Michael S |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-06-13 |
Mcbride Dennis |
Director |
Disposition |
6,320 |
$15.30 |
$96.7K |
- |
| 2023-12-28 |
Rehnquist Janet |
Director |
Unknown |
- |
- |
- |
- |
| 2023-09-13 |
Narido Richard Clavano |
Officer |
Unknown |
- |
- |
- |
- |
| 2023-08-30 |
Hurvitz Chaim |
Director |
Informative Buy |
70,000 |
$0.29 |
$20.13K |
570,000 |
| 2023-08-30 |
Gorovitz Aaron |
Director |
Informative Buy |
35,000 |
$0.32 |
$11.2K |
105,000 |
| 2023-08-23 |
Javitt Jonathan C |
10 Percent Owner, Officer: Chief Scientist |
Informative Buy |
100,000 |
$0.33 |
$33K |
446,332 |
| 2023-08-22 |
Javitt Jonathan C |
10 Percent Owner, Officer: Chief Scientist |
Informative Buy |
200,000 |
$0.32 |
$64.4K |
346,332 |
| 2022-12-31 |
Javitt Jonathan C |
Officer |
Unknown |
- |
- |
- |
- |
| 2022-12-16 |
Van Voorhees Seth |
Chief Financial Officer |
Informative Buy |
30,000 |
$1.10 |
$33K |
46,337 |
| 2022-12-16 |
Willard Stephen H |
Chief Executive Officer |
Informative Buy |
50,000 |
$1.17 |
$58.5K |
50,000 |
| 2022-12-07 |
Javitt Jonathan C |
Director |
Informative Sell |
400,000 |
$1.00 |
$400K |
12,899,997 |
| 2022-11-30 |
Javitt Daniel C. |
Director |
Informative Sell |
8,441 |
$1.50 |
$12.7K |
9,634,793 |
| 2022-11-29 |
Javitt Daniel C. |
Director |
Informative Sell |
13,730 |
$1.50 |
$20.65K |
9,643,234 |
| 2022-11-28 |
Flynn Patrick John |
Director |
Informative Buy |
1,750 |
$1.25 |
$2.19K |
1,750 |
| 2022-11-25 |
Van Voorhees Seth |
Chief Financial Officer |
Informative Buy |
8,716 |
$1.12 |
$9.76K |
8,716 |
| 2022-11-25 |
Van Voorhees Seth |
Chief Financial Officer |
Informative Buy |
8,716 |
$1.12 |
$9.76K |
8,716 |
| 2022-11-18 |
Hurvitz Chaim |
Director |
Informative Buy |
40,408 |
$1.10 |
$44.45K |
500,000 |
| 2022-11-18 |
Hurvitz Chaim |
Director |
Informative Buy |
40,408 |
$1.10 |
$44.45K |
500,000 |
| 2022-11-17 |
Javitt Daniel C. |
Director |
Informative Sell |
33,018 |
$1.05 |
$34.74K |
9,656,964 |
| 2022-11-17 |
Hurvitz Chaim |
Director |
Informative Buy |
171,780 |
$1.08 |
$185.52K |
459,592 |
| 2022-11-17 |
Hurvitz Chaim |
Director |
Informative Buy |
171,780 |
$1.08 |
$185.52K |
459,592 |
| 2022-11-16 |
Javitt Daniel C. |
Director |
Informative Sell |
133,719 |
$1.02 |
$136.39K |
9,689,982 |
| 2022-11-16 |
Hurvitz Chaim |
Director |
Informative Buy |
287,812 |
$0.99 |
$284.93K |
287,812 |
| 2022-11-16 |
Hurvitz Chaim |
Director |
Informative Buy |
287,812 |
$0.99 |
$284.93K |
287,812 |
| 2022-11-11 |
Javitt Daniel C. |
Director |
Informative Sell |
49,200 |
$1.01 |
$49.51K |
9,823,701 |
| 2022-10-21 |
Hurvitz Chaim |
Director |
RSU Award |
162,660 |
- |
- |
381,083 |
| 2022-10-21 |
Gorovitz Aaron |
Director |
RSU Award |
162,660 |
- |
- |
162,660 |
| 2022-10-21 |
Glied Sharon |
Director |
RSU Award |
162,660 |
- |
- |
228,097 |
| 2022-10-21 |
Flynn Patrick John |
Director |
RSU Award |
162,660 |
- |
- |
162,660 |
| 2017-11-20 |
Kim Bennett |
Officer |
Unknown |
- |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
